Pharmaceuticals, Biotechnology and Life Sciences
Meaningful and Durable Responses in Key Endpoints of Six-Minute Walk, Forced Vital Capacity for ERT-Naïve and ERT-Experienced Participants Out to…
CAMBRIDGE, Mass., Feb. 22, 2023 (GLOBE NEWSWIRE) — Jounce Therapeutics, Inc. (Nasdaq: JNCE), a clinical-stage company focused on the discovery…
MALVERN, Pa., Feb. 22, 2023 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on…
Over 49 weeks of DNL310 (ETV:IDS) treatment in the Phase 1/2 study, positive changes across measures of exploratory clinical outcomes…
NEWS RELEASEFEBRUARY 22, 2023, 4:30pm ET/ 22:30 CET Company to Host Conference Call with Live Q&A, March 8,…
Cost-Saving Measures Eliminate Pipeline Programs and Reduce Headcount by 16 PercentCompany will Continue to Drive Trudhesa Growth Via 90 Field-Based…
SOUTH ORANGE, NJ, Feb. 22, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration…
Webcast Scheduled for Wednesday, March 1, 2023, at 4:30 p.m. Eastern SAN DIEGO and GAINESVILLE, Ga., Feb. 22, 2023 (GLOBE…
REDWOOD CITY, Calif., Feb. 22, 2023 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today highlights…
BASEL, Switzerland and LONDON and NEW YORK and BOSTON, Feb. 21, 2023 (GLOBE NEWSWIRE) — Roivant Sciences (Nasdaq: ROIV) today…